Company / Cash per Share
BridgeBio Pharma, Inc. Cash per Share History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$3.00
FY2025
5-year range
$2.50 / $3.89
FY2021-FY2025
Trend
-22.9%
vs FY2024
Sector context
#73 of 205
Health Care
What the data says
At $3.00, BridgeBio Pharma, Inc.'s cash per share ranks #73 of 205 in the Health Care sector. Cash per Share has fluctuated over the past 9 years, ranging from $2.50 in FY2023 to $7.06 in FY2018.
Based on SEC 10-K filings.
3.00 in FY2025 with a 5-year CAGR of +0.8%.
Improved from $2.50 to $3.00 over the past 2 years.
Health Care sector context is included.
Cash per Share over time
Growth rates
- 3-Year CAGR
- +5.5%
- 5-Year CAGR
- +0.8%
- 10-Year CAGR
- -
Sector benchmark
#73 of 205 in Health CareTop 36% of 205This company $3.00 Sector average $67.98
▼
-95.6% below sector average
Key checks
Key Insights
- In FY2025, cash per share decreased 22.9% year-over-year.
- Ranks #73 out of 205 companies in the Health Care sector.
- Peak cash per share was recorded in FY2018.
- Lowest cash per share in the period was in FY2023.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -4.56 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $3.00 | -22.9% |
| FY2024 | $3.89 | +55.6% |
| FY2023 | $2.50 | -2.2% |
| FY2022 | $2.56 | -11.8% |
| FY2021 | $2.90 | +0.7% |
| FY2020 | $2.88 | -27.1% |
| FY2019 | $3.95 | -44.0% |
| FY2018 | $7.06 | +134.8% |
| FY2017 | $3.01 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026